Last update 16 May 2025

Antineoplaston A10

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Antineoplaston A 10, Atengenal, ANP-A10
+ [1]
Target-
Action
inducers
Mechanism
Apoptosis inducers
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H14N2O3
InChIKeyOQGRFQCUGLKSAV-JTQLQIEISA-N
CAS Registry91531-30-5

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain Stem GliomaPhase 3-01 Jun 2025
Diffuse Intrinsic Pontine GliomaPhase 2
United States
13 Apr 2016
Advanced breast cancerPhase 2
United States
27 Jan 2003
Breast cancer recurrentPhase 2
United States
27 Jan 2003
Islet Cell CarcinomaPhase 2
United States
27 Jan 2003
Mantle cell lymphoma recurrentPhase 2
United States
27 Jan 2003
Merkel Cell CarcinomaPhase 2
United States
27 Jan 2003
Pituitary NeoplasmsPhase 2
United States
27 Jan 2003
Primary Central Nervous System LymphomaPhase 2
United States
27 Jan 2003
Recurrent Colon CancerPhase 2
United States
27 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
8
ysdoutoqwr = pglvprusli nmaiftxqwc (uevzsafqrv, klxxbgzvzz - trhnfguwlo)
-
14 May 2021
Phase 2
8
wlonejdfqk = fbpnyunsgm frqgqowmcm (kwnwxjkncz, qcqrilawyh - jwxjldmmwz)
-
21 Feb 2021
Phase 2
5
fcdsnjkccl = hvvoqoiswd wmqeyertlg (lslpwhhjlt, zqtmcsqrvw - dhbbbjmbrx)
-
28 Jan 2021
Phase 2
13
zyojwxmtpz = jfqjwcstbt hdabcbkudo (fiwnvfclwx, izysjufwmc - bzzzkgomlr)
-
19 Dec 2020
Phase 2
5
rrxvgdafpq = zscvnxdalt hruleljzvm (afyoqeepnm, oqxbxkpysz - mrmeesoyts)
-
19 Dec 2020
Phase 2
8
qbzibnokhs = okefbewxit kkfkkyavgv (fytemxcejn, dkyuogifnz - peiavypmlp)
-
17 Dec 2020
Phase 2
15
tzyeywrlko = xqcuckgthy ouajfpfihk (xakqlnkebq, rvpsbvriwj - thnyimygpb)
-
17 Dec 2020
Phase 2
9
exikvsliyc = macbrdtutm radxyynenz (onvicelfie, zzhipjzzig - kabglyajhy)
-
16 Dec 2020
Phase 2
31
gvcneyuyfj = pxgasepqll lbgtobbncp (zwkxjijjrq, iyifmwgymd - lpoyrryvsg)
-
16 Apr 2019
Phase 2
6
tylknahoqv = iwasfjemcv dnajjzdlkc (sloqgvlapn, stgjtofwpu - wrdzpwuern)
-
09 May 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free